chr2-199272595-C-A
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001172509.2(SATB2):c.1818G>T(p.Pro606Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00207 in 1,613,998 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P606P) has been classified as Likely benign.
Frequency
Consequence
NM_001172509.2 synonymous
Scores
Clinical Significance
Conservation
Publications
- chromosome 2q32-q33 deletion syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- SATB2 associated disorderInheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SATB2 | NM_001172509.2 | c.1818G>T | p.Pro606Pro | synonymous_variant | Exon 11 of 11 | ENST00000417098.6 | NP_001165980.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00155 AC: 235AN: 152008Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00193 AC: 483AN: 250772 AF XY: 0.00195 show subpopulations
GnomAD4 exome AF: 0.00213 AC: 3107AN: 1461872Hom.: 8 Cov.: 31 AF XY: 0.00205 AC XY: 1493AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00154 AC: 235AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.00149 AC XY: 111AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
SATB2: BP4, BP7 -
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
SATB2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Chromosome 2q32-q33 deletion syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at